LLY compared with VTGN: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

VTGNVistagen Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

VTGNVistagen Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,369.00· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

VTGNVistagen Therapeutics, Inc.

0.19▲+1.63%· post 0.17· delayed

After hoursNov 5 '26delayed

Mkt cap$8.2MRevenue$1MQ1 FY27Revenue$1MFY26

Compare

After hoursNov 5 '26delayed

LLYELI Lilly & Co

VTGNVistagen Therapeutics, Inc.

1,371.32▼−3.29%post 1,369.00delayed

Price

0.19▲+1.63%post 0.17delayed

$1.3T

Mkt cap

$8.2M

Q3 FY26$24.4B

Revenue

$1MQ1 FY27

FY25$65.2B

Revenue

$1MFY26

LLY1,371.32▼−3.29%vsVTGN0.19▲+1.63%After hoursNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

VTGN: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only VTGN 4

—Pherin Pharmaceuticals, Inc. (Pherin)unlistedsupplier

—AffaMedunlistedcustomer

—AffaMed Therapeuticsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Fuji Pharmaunlistedcustomer

Price

rebased to 0%

LLY, solidVTGN, dashed